Correlation Between Bristol Myers and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Allogene Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Allogene Therapeutics.
Diversification Opportunities for Bristol Myers and Allogene Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bristol and Allogene is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Allogene Therapeutics
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.4 times more return on investment than Allogene Therapeutics. However, Bristol Myers Squibb is 2.47 times less risky than Allogene Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Allogene Therapeutics is currently generating about -0.27 per unit of risk. If you would invest 5,017 in Bristol Myers Squibb on February 29, 2024 and sell it today you would lose (968.00) from holding Bristol Myers Squibb or give up 19.29% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Bristol Myers Squibb vs. Allogene Therapeutics
Performance |
Timeline |
Bristol Myers Squibb |
Allogene Therapeutics |
Bristol Myers and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol Myers and Allogene Therapeutics
The main advantage of trading using opposite Bristol Myers and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.Bristol Myers vs. Universe Pharmaceuticals | Bristol Myers vs. Akanda Corp | Bristol Myers vs. Petros Pharmaceuticals | Bristol Myers vs. Sunshine Biopharma |
Allogene Therapeutics vs. G1 Therapeutics | Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. AnnexonInc | Allogene Therapeutics vs. Sangamo Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |